Dr. Elliot Lander, co-medical director of the Cell Surgical Network, will present 2 research abstracts at the American Urologic Association Western Section Annual Meeting in Monterey California Nov 2013. These abstracts will highlight some of our ongoing studies for the use of SVF (rich in mesenchymal stem cells and growth factors) to treat complex urologic diseases.
The following abstracts will be presented:
Autologous Adipose Derived Stromal Vascular Fraction Combined with Low Intensity Shock Wave Therapy for the Treatment of Peyronies Disease‐ A
Autologous Adipose Derived Stromal Vascular Fraction for the Treatment of Interstitial cystitis‐ A Pilot Study.